ArticleJournal of experimental & clinical cancer research : CR2025

Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients.

Amalia Azzariti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.